↓ Skip to main content
Dove Medical Press
Article Metrics
What is this page?
Embed badge
Share
Share on Twitter
Share on Facebook
Share by email
Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia
Overview of attention for article published in Drug Design, Development and Therapy, March 2021
Altmetric Badge
About this Attention Score
Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)
Mentioned by
twitter
3
X users
reddit
1
Redditor
Citations
dimensions_citation
7
Dimensions
Readers on
mendeley
20
Mendeley
Summary
X
Reddit
Dimensions citations
So far, Altmetric has seen
1
Reddit thread.
Zanubrutinib (BGB-3111), a second-generation selective coval | DDDT
User
HighYield
,
06 Mar 2021